ADMA Biologics Inc (ADMA)
21.18
-0.12
(-0.56%)
USD |
NASDAQ |
Nov 22, 16:00
21.21
+0.03
(+0.14%)
After-Hours: 20:00
ADMA Biologics Cash from Financing (Quarterly): -25.47M for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -25.47M |
| June 30, 2024 | -0.362M |
| March 31, 2024 | -1.447M |
| December 31, 2023 | -39.00M |
| September 30, 2023 | 0.416M |
| June 30, 2023 | 0.24M |
| March 31, 2023 | -0.65M |
| December 31, 2022 | 62.74M |
| September 30, 2022 | -0.8438M |
| June 30, 2022 | -0.319M |
| March 31, 2022 | 47.27M |
| December 31, 2021 | 53.82M |
| September 30, 2021 | 8.203M |
| June 30, 2021 | 17.18M |
| March 31, 2021 | 41.84M |
| December 31, 2020 | 32.06M |
| September 30, 2020 | 10.63M |
| June 30, 2020 | -0.0017M |
| March 31, 2020 | 101.20M |
| December 31, 2019 | -0.0077M |
| September 30, 2019 | -0.0076M |
| June 30, 2019 | 75.84M |
| March 31, 2019 | 4.177M |
| December 31, 2018 | -0.0005M |
| September 30, 2018 | -0.0129M |
| Date | Value |
|---|---|
| June 30, 2018 | 42.94M |
| March 31, 2018 | -0.0044M |
| December 31, 2017 | 50.37M |
| September 30, 2017 | -1.663M |
| June 30, 2017 | 13.15M |
| March 31, 2017 | -1.115M |
| December 31, 2016 | -0.0039M |
| September 30, 2016 | -0.1989M |
| June 30, 2016 | 17.04M |
| March 31, 2016 | -0.0037M |
| December 31, 2015 | -0.0593M |
| September 30, 2015 | -0.1281M |
| June 30, 2015 | 0.1297M |
| March 31, 2015 | 10.46M |
| December 31, 2014 | 5.039M |
| September 30, 2014 | -0.0491M |
| June 30, 2014 | 0.0164M |
| March 31, 2014 | 4.789M |
| December 31, 2013 | 26.67M |
| September 30, 2013 | -0.0314M |
| June 30, 2013 | 0.0687M |
| March 31, 2013 | 0.9257M |
| December 31, 2012 | 3.658M |
| September 30, 2012 | -0.0388M |
| June 30, 2012 | -0.299M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-39.00M
Minimum
Dec 2023
101.20M
Maximum
Mar 2020
15.38M
Average
0.328M
Median
Cash from Financing (Quarterly) Benchmarks
| Corcept Therapeutics Inc | -21.09M |
| Madrigal Pharmaceuticals Inc | 7.462M |
| Assembly Biosciences Inc | 0.00 |
| TG Therapeutics Inc | 134.45M |
| Krystal Biotech Inc | 3.365M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 25.03M |
| Cash from Investing (Quarterly) | -1.098M |
| Free Cash Flow | 78.82M |
| Free Cash Flow Per Share (Quarterly) | 0.0978 |
| Free Cash Flow to Equity (Quarterly) | 53.68M |
| Free Cash Flow to Firm (Quarterly) | 26.70M |
| Free Cash Flow Yield | 1.57% |